API
< Back to all clusters
[HEALTH] · Germany · 2 sources

started · updated

Study Shows 91% of Drug Candidates Fail in Human Trials After Successful Animal Tests

An international research team of 13 scientists from six countries examined drug development data from the 1960s to 2017. The analysis found that, despite a rise in animal testing, the overall success rate of bringing new medicines to market has not improved.

In the 2000s and 2010s, roughly 91 % of drug candidates that passed pre‑clinical animal studies failed in subsequent human clinical trials. About 77 % of those failures were due to biological reasons such as insufficient efficacy or safety—outcomes that animal tests are intended to predict. The authors argue that these figures demonstrate a systematic shortfall of animal experiments and underscore the urgent need for human‑relevant, animal‑free drug development methods. The study was coordinated by the German association Ärzte gegen Tierversuche e.V., with Dr. Wolfgang Boomgaarden, a prize‑winning expert in computational, animal‑free approaches, among the contributors.

Entities

International research team · Wolfgang Boomgaarden · Ärzte gegen Tierversuche e.V.